Louisiana State Employees Retirement System maintained its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,900 shares of the company’s stock at the end of the second quarter. Louisiana State Employees Retirement System’s holdings in Henry Schein were worth $897,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently modified their holdings of the company. Girard Partners LTD. boosted its stake in shares of Henry Schein by 0.3% in the first quarter. Girard Partners LTD. now owns 3,115 shares of the company’s stock valued at $529,000 after buying an additional 10 shares during the last quarter. Cleararc Capital Inc. boosted its stake in shares of Henry Schein by 0.6% in the first quarter. Cleararc Capital Inc. now owns 1,950 shares of the company’s stock valued at $331,000 after buying an additional 11 shares during the last quarter. Penserra Capital Management LLC boosted its stake in shares of Henry Schein by 1.0% in the first quarter. Penserra Capital Management LLC now owns 1,518 shares of the company’s stock valued at $258,000 after buying an additional 15 shares during the last quarter. Wetherby Asset Management Inc. boosted its stake in shares of Henry Schein by 0.7% in the first quarter. Wetherby Asset Management Inc. now owns 3,147 shares of the company’s stock valued at $535,000 after buying an additional 21 shares during the last quarter. Finally, Mn Services Vermogensbeheer B.V. boosted its stake in shares of Henry Schein by 2.0% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 2,147 shares of the company’s stock valued at $341,000 after buying an additional 43 shares during the last quarter. Hedge funds and other institutional investors own 90.60% of the company’s stock.
Shares of Henry Schein, Inc. (NASDAQ HSIC) traded down 0.07% during trading on Friday, hitting $169.49. The stock had a trading volume of 525,408 shares. Henry Schein, Inc. has a 12-month low of $146.23 and a 12-month high of $186.99. The stock’s 50 day moving average is $179.49 and its 200-day moving average is $175.49. The company has a market cap of $13.40 billion, a PE ratio of 24.77 and a beta of 1.09. Henry Schein shares are set to split on the morning of Friday, September 15th. The 2-1 split was announced on Wednesday, August 16th. The newly minted shares will be issued to shareholders after the market closes on Thursday, September 14th.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 8th. The company reported $1.75 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.73 by $0.02. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The firm had revenue of $3.06 billion during the quarter, compared to the consensus estimate of $3.05 billion. During the same quarter in the previous year, the business earned $1.64 earnings per share. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. Analysts forecast that Henry Schein, Inc. will post $7.27 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: This news story was published by BNB Daily and is the sole property of of BNB Daily. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://www.baseball-news-blog.com/2017/08/19/louisiana-state-employees-retirement-system-has-897000-position-in-henry-schein-inc-nasdaqhsic-updated-updated.html.
Several analysts recently commented on the company. Jefferies Group LLC reiterated a “hold” rating and set a $177.00 price target on shares of Henry Schein in a research report on Friday, July 21st. Zacks Investment Research upgraded Henry Schein from a “hold” rating to a “buy” rating and set a $190.00 price target for the company in a research report on Tuesday, April 25th. Stifel Nicolaus reiterated a “hold” rating on shares of Henry Schein in a research report on Thursday, July 6th. Barrington Research boosted their price target on Henry Schein from $196.00 to $198.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 10th. Finally, Northcoast Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price target for the company in a research report on Monday, August 7th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have given a buy rating to the company’s stock. Henry Schein presently has a consensus rating of “Hold” and a consensus price target of $185.56.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.